ATE539155T1 - Targets und zusammensetzungen zur therapeutischen intervention bei hiv-infektion - Google Patents

Targets und zusammensetzungen zur therapeutischen intervention bei hiv-infektion

Info

Publication number
ATE539155T1
ATE539155T1 AT07015899T AT07015899T ATE539155T1 AT E539155 T1 ATE539155 T1 AT E539155T1 AT 07015899 T AT07015899 T AT 07015899T AT 07015899 T AT07015899 T AT 07015899T AT E539155 T1 ATE539155 T1 AT E539155T1
Authority
AT
Austria
Prior art keywords
targets
therapeutic intervention
compositions
hiv infection
intervention
Prior art date
Application number
AT07015899T
Other languages
English (en)
Inventor
Annette Friebe
Hanjo Hennemann
Claudia Carl
Nina Schuermann
Sabine Wirths
Original Assignee
Nexigen Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexigen Gmbh filed Critical Nexigen Gmbh
Application granted granted Critical
Publication of ATE539155T1 publication Critical patent/ATE539155T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07015899T 2007-08-13 2007-08-13 Targets und zusammensetzungen zur therapeutischen intervention bei hiv-infektion ATE539155T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07015899A EP2025750B1 (de) 2007-08-13 2007-08-13 Targets und Zusammensetzungen zur therapeutischen Intervention bei HIV-Infektion

Publications (1)

Publication Number Publication Date
ATE539155T1 true ATE539155T1 (de) 2012-01-15

Family

ID=38984065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07015899T ATE539155T1 (de) 2007-08-13 2007-08-13 Targets und zusammensetzungen zur therapeutischen intervention bei hiv-infektion

Country Status (9)

Country Link
US (1) US8685652B2 (de)
EP (2) EP2025750B1 (de)
JP (1) JP2010535846A (de)
AT (1) ATE539155T1 (de)
CA (1) CA2700923A1 (de)
DK (1) DK2025750T3 (de)
ES (1) ES2378852T3 (de)
IL (1) IL203873A0 (de)
WO (1) WO2009021971A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130039857A1 (en) * 2010-03-22 2013-02-14 Jeffrey E. Pessin Methods of suppressing cancer, increasing weight loss and/or increasing insulin sensitivity
CN102516370A (zh) * 2011-12-16 2012-06-27 吉林大学第一医院 抗hiv的药物靶点及其在制药中的用途
EP2879675B1 (de) 2012-08-06 2019-11-13 Duke University Auf hsp90 gerichtete verbindungen und verfahren
US10398772B2 (en) * 2014-01-08 2019-09-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
WO2017184956A1 (en) 2016-04-22 2017-10-26 Duke University Compounds and methods for targeting hsp90
CN108588081A (zh) * 2018-02-01 2018-09-28 上海市东方医院 一种靶向细胞核的序列及其应用
EP3969027B1 (de) * 2019-05-16 2024-02-28 Saint Joseph's University Polypeptide zur behandlung von krebs
EP4046688B1 (de) * 2019-10-18 2025-04-09 Takeda Pharmaceutical Company Limited Heterocyclische verbindung
JP7863505B2 (ja) * 2019-12-17 2026-05-21 オリオニス バイオサイエンシズ，インコーポレイテッド 分子相互作用の検出
EP4615415A4 (de) * 2022-11-11 2026-08-12 Mayo Found Medical Education & Res Behandlung von proteinopathien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004012406T2 (de) 2003-05-23 2009-04-30 Oregon Health & Science University, Portland Verfahren zur identifikation von inhibitoren
JP4653103B2 (ja) * 2003-06-10 2011-03-16 ザ ジェイ．ディヴィッド グラッドストン インスティテューツ レンチウイルス感染症を治療するための方法
CA2537798A1 (en) 2003-09-03 2005-03-17 University Of Rochester Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
CA2628863A1 (en) 2005-10-06 2007-04-19 University Of Massachusetts Composition and synthesis of new reagents for inhibition of hiv replication

Also Published As

Publication number Publication date
EP2025750B1 (de) 2011-12-28
ES2378852T3 (es) 2012-04-18
EP2185703A2 (de) 2010-05-19
IL203873A0 (en) 2011-07-31
US20110065198A1 (en) 2011-03-17
CA2700923A1 (en) 2009-02-19
EP2025750A1 (de) 2009-02-18
JP2010535846A (ja) 2010-11-25
US8685652B2 (en) 2014-04-01
WO2009021971A2 (en) 2009-02-19
WO2009021971A3 (en) 2009-04-02
DK2025750T3 (da) 2012-02-20

Similar Documents

Publication Publication Date Title
IL203873A0 (en) Novel targets and compounds for therapeutic intervention of hiv infection
CY1110665T1 (el) Αναστολεις hiv ιντεγκρασης
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
NZ585226A (en) Inhibitors of human immunodeficiency virus replication
WO2008127364A3 (en) Antiviral compounds and use thereof
ATE522216T1 (de) Verwendung von 2-6-(3-amin-piperidin-1-yl)-3- methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1- ylmethyl-4-fluor-benzonitril zur behandlung von diabetes, krebs, autoimmunerkrankungen und hiv- infektionen
MX2012001974A (es) Compuestos de biarilo y metodos de uso de los mismos.
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
IL199152A (en) Annals 2 - (piperidine-4-ram) -4-phenoxy or phenylamino-pyrimidine, containing and containing pharmaceutical preparations for the preparation of viral infections
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
UY29041A1 (es) Derivados de amino-piperidina, su preparacion y su utilización en terapeutica
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
CL2008002291A1 (es) Compuestos derivados del acido 4-fluor-benzoico, inhibidores de la polimerasa hcv, composicion farmaceutica, kit farmaceutico y su uso para el tratamiento de una infeccion viral por hepatitis c.
BRPI0814363A2 (pt) Produtos fármacos de interferon de liberação controlada e tratamento de infecção por hcv usando os mesmos
UY29876A1 (es) Derivados de acidos dicarboxilicos y su uso
ATE534652T1 (de) Phosphono-pent-2-en-1-yl-nukleoside und analoga
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
UY28313A1 (es) Nonadepsipeptidos acilados
CY1114757T1 (el) Παραγωγα οξαζινης και η χρηση τους στη θεραπεια νευρολογικων διαταραχων
AR053775A1 (es) Nonadepsipeptidos acilados ii
NI201100178A (es) Derivados de indol y métodos para el tratamiento antiviral
ATE433459T1 (de) Desoxo-nonadepsipeptide
PA8624401A1 (es) Procesos para la preparacion de haluros de aril- y heteroaril-alquilsulfonilo
BRPI0913586A8 (pt) combinação, e, uso de uma combinação.